Short-form briefs from the morning scrape — 150–250 words.
Concentrated 7-OH products go Schedule I no earlier than August 5. Botanical kratom stays legal — and the kratom industry itself is glad.
The DEA's temporary Schedule I action targets concentrated 7-hydroxymitragynine products, not the botanical kratom leaf — a distinction that matters for anyone using either.
9 total in this section
HHS Secretary Kennedy announced $700M+ in new behavioral health funding on June 17 — the same week organizations reckoned with the April fentanyl test strip ban. The two actions aren't contradictory. They describe the same framework: treatment yes, harm reduction no.
Nitazene overdose deaths rose from 27 in 2020 to 409 in 2024 — a 1,400% increase in four years. With 26 compounds now detected in the U.S. supply, some more potent than fentanyl, the surveillance data is always a year late.
The Log
Every piece in this section, most recent first.